104,140 Shares in Merck KGaA $MKGAF Bought by First Nebraska Trust Co

Posted by Doug Wharley on Aug 23rd, 2026

First Nebraska Trust Co purchased a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 104,140 shares of the company’s stock, valued at approximately $13,382,000. Merck KGaA comprises about 1.1% of First Nebraska Trust Co’s investment portfolio, making the stock its 23rd largest position. First Nebraska Trust Co owned approximately 0.08% of Merck KGaA at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. Frazier Financial Advisors LLC bought a new position in shares of Merck KGaA during the second quarter valued at about $25,000. Rakuten Securities Inc. bought a new stake in shares of Merck KGaA in the 2nd quarter valued at about $27,000. Bard Associates Inc. purchased a new stake in Merck KGaA during the 2nd quarter valued at about $60,000. Kilter Group LLC purchased a new stake in Merck KGaA during the 2nd quarter valued at about $62,000. Finally, Addison Advisors LLC bought a new position in Merck KGaA during the 2nd quarter worth approximately $90,000. 0.10% of the stock is currently owned by hedge funds and other institutional investors.

Merck KGaA Price Performance

MKGAF opened at $163.21 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The stock’s 50 day simple moving average is $162.62 and its 200 day simple moving average is $148.46. The firm has a market cap of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56.

Merck KGaA Company Profile

(Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.